New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
10:31 EDTABB, LINE, EVEP, LNCO, DOX, NSR, FNP, SYMC, NUAN, CCJ, MEMP, HPT, CYTXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Cytori Therapeutics (CYTX) initiated with a Buy at Ascendiant Capital... Hospitality Properties (HPT) initiated with a Market Perform at JMP Securities... Memorial Production (MEMP) initiated with a Buy at Wunderlich... Roadrunner (RRTS) initiated with a Buy at Deutsche Bank... Cameco (CCJ) initiated with a Buy at Cantor... Symantec (SYMC) initiated with a Buy at B. Riley Caris... Nuance (NUAN) initiated with a Neutral at B. Riley Caris... NeuStar (NSR) initiated with a Neutral at B. Riley Caris... Fifth & Pacific (FNP) initiated with a Buy at BB&T... Amdocs (DOX) initiated with a Neutral at B. Riley Caris... EV Energy (EVEP) initiated with an Overweight at JPMorgan... LinnCo (LNCO) initiated with an Overweight at JPMorgan... LINN Energy (LINE) initiated with an Overweight at JPMorgan... ABB (ABB) initiated with an Outperform at Credit Suisse.
News For CYTX;HPT;MEMP;CCJ;NUAN;SYMC;FNP;NSR;DOX;LNCO;EVEP;LINE;ABB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
08:35 EDTCCJCameco now sees FY14 revenue flat to down 5% vs. FY13
Subscribe for More Information
08:33 EDTCCJCameco reports Q3 adjusted EPS C23c, consensus 24c
Subscribe for More Information
October 27, 2014
08:12 EDTABBAccenture, Structure team with UIL Holdings
Subscribe for More Information
October 23, 2014
09:04 EDTCYTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:17 EDTSYMCIDC says IBM should look at Symantec info-management unit, Bloomberg reports
Analysts have said acquisitions would be a better use of IBM's (IBM) cash than share repurchases and IDC Corp. pointed to Symantecís (SYMC) information-management division and cloud-storage provider Box as two logical options, reported Bloomberg's "Real M&A" column. Reference Link
October 22, 2014
18:19 EDTCYTXCytori Therapeutics receives FDA approval to resume ATHENA trial enrollment
Cytori Therapeutics has received notification from the FDA that Cytori has provided additional information sufficient to support continuation of enrollment in its ATHENA cardiovascular trials. The FDA has agreed that the submitted data and protocol amendments support the fact that there are no subject protection concerns that preclude continuation of the trials. The ATHENA trials have enrolled a total of 31 patients thus far but enrollment was stopped last May by the company based on meeting the trialsí internal stopping rules related to potential cerebrovascular events affecting both cell and placebo treated patients. Based on consultation with the FDA, Cytori initiated a thorough safety review consisting of evaluating each adverse event in all of its previous and ongoing cardiovascular trials and conducted additional testing of its product and cellular output. In addition, Cytori implemented several protocol changes to enhance the safety of the trial procedures for patients. The FDA response to Cytoriís submission was received on October 22.
12:19 EDTLINEOptions with decreasing implied volatility
Subscribe for More Information
08:39 EDTABBSiemens sees catching up with rivals on sales growth in 2018, Reuters reports
Subscribe for More Information
06:44 EDTSYMCU.S. weighing cybersecurity requirements for bank vendors, NY Times says
Subscribe for More Information
October 20, 2014
07:56 EDTHPTHospitality Properties upgraded at Stifel
Subscribe for More Information
07:22 EDTABBSolar Energy Trade Shows to hold a conference
Subscribe for More Information
06:43 EDTHPTHospitality Properties upgraded to Buy from Hold at Stifel
05:49 EDTNUANStocks with implied volatility movement; TLM NUAN
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use